Skip to content
Snippets Groups Projects
Commit 2e38ea16 authored by Isabell Alexandra Guckes's avatar Isabell Alexandra Guckes
Browse files

Update file drug-data.tsx

parent 9e257ad6
No related branches found
No related tags found
No related merge requests found
......@@ -4,7 +4,7 @@ export interface DrugDatensatz {
picture: string;
introduction: string;
examples: Array<example>;
}
......@@ -37,7 +37,7 @@ export const drugdata: (Array<DrugDatensatz>) = [
examples: [
{
title: "Trikafta", //quelle 4
text: ["Active ingredient(s): Combination of elexacaftor/tezacaftor/ivacaftor","Indications: For CF patients aged 2 years and older with at least one F508del mutation à 85 % of CF patients","Mechanism: Elexacaftor and tezacaftor act as correctors on misfolded CFTR and permit delivery to the cell surface, thereby improving the channel density at the plasma membrane, while ivacaftor as a potentiator acts on CFTR channels that have reached the cell surface and increase the gating and conductance of ions [5].","Administration: Oral tablets","Approval: Approved by the EMA in 2020 "]
text: ["Active ingredient(s): Combination of elexacaftor/tezacaftor/ivacaftor","Indications: For CF patients aged 2 years and older with at least one F508del mutation = 85 % of CF patients","Mechanism: Elexacaftor and tezacaftor act as correctors on misfolded CFTR and permit delivery to the cell surface, thereby improving the channel density at the plasma membrane, while ivacaftor as a potentiator acts on CFTR channels that have reached the cell surface and increase the gating and conductance of ions [5].","Administration: Oral tablets","Approval: Approved by the EMA in 2020 "]
},
{
title: "Symdeko", //quelle 1
......
0% Loading or .
You are about to add 0 people to the discussion. Proceed with caution.
Finish editing this message first!
Please register or to comment